ASND three-lens brief
Evidence-based stock research on ASND. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
50-day MA above 200-day MA (golden-cross regime); price above both. · Earnings in today (2026-11-12).
- 50-day MA above 200-day MA (golden-cross regime); price above both.
- Outperforming SPY by 14.2pp over 30 days.
- Analyst mean target $302.35 — 17% above current (21 analysts).
- Reported earnings on 2026-11-12.
- Earnings in today (2026-11-12).
ASND closed at $259.28 (+1.05%) as of 2026-11-12. Market cap: $17.06B. P/E (trailing) 19.7. Price is above the 50-day MA and above the 200-day MA. Positives: 50-day MA above 200-day MA (golden-cross regime); price above both.; outperforming SPY by 14.2pp over 30 days.. Concerns: earnings in today (2026-11-12).. Last quarter: Revenue $246.60M, net income $629.34M, free cash flow $12.77M. Watching for: 2026-11-12 earnings release (today).
Why three lenses on ASND, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ASND across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/ASND" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ASND brief"></iframe>